Clinical Trial Update: Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating focal therapy with stereotactic body radiation therapy (SBRT) for a single prostate tumor; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostatic Neoplasms, Prostate Cancer | Phase 2 | Status: RECRUITING